In Vitro Activity of the Oxazolidinone RWJ-416457 against Linezolid-Resistant and -Susceptible Staphylococci and Enterococci
- 1 March 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (3) , 1112-1114
Abstract
RWJ-416457, a novel oxazolidinone, had modal MICs of 0.5 to 1 μg/ml for linezolid-susceptible staphylococci and enterococci, versus linezolid MICs for these organisms of 1 or 2 μg/ml. RWJ-416457 MICs for mutants with 23S rRNA mutations were 2 to 32 μg/ml, versus linezolid MICs of 8 to 64 μg/ml; actual values reflected the proportion of gene copies mutated.Keywords
This publication has 13 references indexed in Scilit:
- In Vitro Antibacterial Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457Antimicrobial Agents and Chemotherapy, 2007
- Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue InfectionsAntimicrobial Agents and Chemotherapy, 2005
- Antimicrobial Resistance to LinezolidClinical Infectious Diseases, 2004
- Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance ProgrammeJournal of Antimicrobial Chemotherapy, 2004
- Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.2003
- Linezolid vs Vancomycin *Chest, 2003
- Rapid Detection and Estimation by Pyrosequencing of 23S rRNA Genes with a Single Nucleotide Polymorphism Conferring Linezolid Resistance in EnterococciAntimicrobial Agents and Chemotherapy, 2003
- Linezolid in vitro: mechanism and antibacterial spectrumJournal of Antimicrobial Chemotherapy, 2003
- Efficacy of linezolid versus comparator therapies in Gram-positive infectionsJournal of Antimicrobial Chemotherapy, 2003
- Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS)Journal of Antimicrobial Chemotherapy, 2001